Publikasi Scopus FKUI Tahun 2010 s/d 2020 (data Per 3 Februari 2021)

Omata M., Lesmana L.A., Tateishi R., Chen P.-J., Lin S.-M., Yoshida H., Kudo M., Lee J.M., Choi B.I., Poon R.T.P., Shiina S., Cheng A.L., Jia J.-D., Obi S., Han K.H., Jafri W., Chow P., Lim S.G., Chawla Y.K., Budihusodo U., Gani R.A., Lesmana C.R., Putranto T.A., Liaw Y.F., Sarin S.K.
36043368300;55920139300;7005617531;7408354514;7407154488;55496666300;55216757300;57203727958;7402755373;7103097223;7005392858;56723366300;7202343661;7005358917;7402963689;23091123700;7202656968;7404081127;24310061500;24785711400;23495930300;8977683000;57190940542;57210820004;7102500714;
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
2010
Hepatology International
4
2
439
474
753
Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; Liver Research Unit, Chang Gung Memorial Hospital, Taipei, Taiwan; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, Osaka-Sayama, Japan; Abdominal Radiology Section, Department of Radiology, Seoul National University Hospital, Seoul, South Korea; Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong; Department of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; Division of Hepatology, Kyoundo Hospital, Tokyo, Japan; Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, South Korea; Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan; Department of General Surgery, Singapore General Hospital, Singapore, Singapore; Department of Gastroenterology and Hepatology, National University Hospital, Singapore, Singapore; Departments of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; Hepatology Division, Internal Medicine Department, RSUPN Cipto Mangunkusumo, Jakarta, Indonesia; Department of Radiology, Central Army Hospital, Jakarta, Indonesia; Department of Gastroenterology, G. B. Pant Hospital, University of Delhi, New Delhi, India
Omata, M., Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Lesmana, L.A., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Tateishi, R., Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Chen, P.-J., Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; Lin, S.-M., Liver Research Unit, Chang Gung Memorial Hospital, Taipei, Taiwan; Yoshida, H., Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Kudo, M., Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, Osaka-Sayama, Japan; Lee, J.M., Abdominal Radiology Section, Department of Radiology, Seoul National University Hospital, Seoul, South Korea; Choi, B.I., Abdominal Radiology Section, Department of Radiology, Seoul National University Hospital, Seoul, South Korea; Poon, R.T.P., Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong; Shiina, S., Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Cheng, A.L., Department of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Jia, J.-D., Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; Obi, S., Division of Hepatology, Kyoundo Hospital, Tokyo, Japan; Han, K.H., Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, South Korea; Jafri, W., Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan; Chow, P., Department of General Surgery, Singapore General Hospital, Singapore, Singapore; Lim, S.G., Department of Gastroenterology and Hepatology, National University Hospital, Singapore, Singapore; Chawla, Y.K., Departments of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; Budihusodo, U., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Gani, R.A., Hepatology Division, Internal Medicine Department, RSUPN Cipto Mangunkusumo, Jakarta, Indonesia; Lesmana, C.R., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Putranto, T.A., Department of Radiology, Central Army Hospital, Jakarta, Indonesia; Liaw, Y.F., Liver Research Unit, Chang Gung Memorial Hospital, Taipei, Taiwan; Sarin, S.K., Department of Gastroenterology, G. B. Pant Hospital, University of Delhi, New Delhi, India
Introduction: The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations. Methods: The working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements. Results: Participants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference. © 2010 Asian Pacific Association for the Study of the Liver.
Consensus statements; Diagnosis; Epidemiology; Hepatocellular carcinoma; Recommendations; Treatment algorithm
aflatoxin; alpha fetoprotein; bevacizumab; capecitabine; cetuximab; cisplatin; decarboxyprothrombin; doxorubicin; epidermal growth factor receptor antibody; epirubicin; erlotinib; farnoquinone; fluorouracil; gefitinib; gemcitabine; glitazone derivative; glypican 3; hepatitis B vaccine; interferon; lamivudine; metformin; mitomycin C; mitoxantrone; oxaliplatin; placebo; sorafenib; sunitinib; thalidomide; tumor marker; unindexed drug; advanced cancer; alcohol consumption; antineoplastic activity; ascites; bleeding; bone marrow suppression; cancer screening; cardiotoxicity; chemoembolization; clinical trial; coffee; computer assisted tomography; constipation; desquamation; diagnostic test; diarrhea; dizziness; drug efficacy; drug eruption; drug safety; drug tolerability; echography; edema; evi
Springer New York
19360533
Review
Q1